Stay updated on Inetetamab Plus Rapamycin for HER2+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Inetetamab Plus Rapamycin for HER2+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Inetetamab Plus Rapamycin for HER2+ Breast Cancer Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    No additions or deletions are present in the study record history for this page, so the historical view remains unchanged.
    Difference
    0.1%
    Check dated 2026-09-12T17:41:35.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page's revision was updated from v3.6.5 to v3.6.6, reflecting a metadata update to the study record history. This indicates an update to the page's versioning rather than new study information.
    Difference
    0.1%
    Check dated 2026-08-29T19:42:49.000Z thumbnail image
  4. Check
    23 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    The record history now shows a new revision label (v3.6.5), indicating an update to the study record.
    Difference
    0.1%
    Check dated 2026-08-08T16:13:23.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The record history now shows a new revision entry 'Revision: v3.6.4', replacing the previous 'Revision: v3.6.3'. This indicates a page update to the ClinicalTrials.gov study record.
    Difference
    0.1%
    Check dated 2026-07-25T06:42:16.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The study record history is updated with a new revision entry for v3.6.3. The previous v3.6.2 entry is removed from the visible history.
    Difference
    0.1%
    Check dated 2026-07-03T20:52:41.000Z thumbnail image
  8. Check
    80 days ago
    Change Detected
    Summary
    The revision label on the history page was updated from v3.6.0 to v3.6.2, reflecting a new software release.
    Difference
    0.1%
    Check dated 2026-06-26T20:04:30.000Z thumbnail image

Stay in the know with updates to Inetetamab Plus Rapamycin for HER2+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Inetetamab Plus Rapamycin for HER2+ Breast Cancer Clinical Trial page.